|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Martin-Luther-Universität Halle-Wittenberg, Institut für Biotechnologie, 06120 Halle, Germany
2 Martin-Luther-Universität Halle-Wittenberg, Institut für Biochemie, 06120 Halle, Germany
(RECEIVED May 31, 2006; FINAL REVISION November 29, 2006; ACCEPTED November 30, 2006)
| Abstract |
|---|
|
|
|---|
G = 20.9 kJ/mol that was subdivided into two reactions, native
intermediate state (14.8 kJ/mol) and intermediate
unfolded state (6.1 kJ/mol). An additional very fast unfolding reaction was observed using circular dichroism (CD), indicating the presence of at least two kinetically populated intermediates in the unfolding of proNGF. The part of the pro-peptide involved in the intramolecular association with mature NGF comprised the peptide Trp83-Ala63 as determined by H/D exchange experiments. Spectroscopic analyses revealed that on the NGF side, a surface area around Trp21 interacted with the pro-peptide. Trp21 also participates in binding to TrkA and p75 receptors. These overlapping binding sites of the pro-peptide and the NGF receptors might explain the previously observed lower affinity of proNGF to its receptors as compared to NGF. Keywords: pro-peptide; proNGF; NGF; folding; receptor binding; TrkA; p75; Trp21
| Introduction |
|---|
|
|
|---|
The pro-peptide acts in vitro as an intramolecular chaperone by facilitating and stimulating oxidative folding of the mature part (Rattenholl et al. 2001a,b). Folding-promoting functions of pro-peptides have been reported for several proteins, which are expressed as (pre-)pro-proteins (Shinde and Inouye 2000). Prominent examples are bovine pancreatic trypsin inhibitor (BPTI), guanylyl cyclase activating peptide (GCAP), or the macrophage inhibitory cytokine-1 (MIC-1), and proteases such as
-lytic protease, subtilisin, and carboxypeptidase Y (Ikemura et al. 1987; Winther and Sorensen 1991; Weissman and Kim 1992; Shinde et al. 1993; Hidaka et al. 1998; Fairlie et al. 2001). The pro-peptides of the
-conotoxins, toxins of marine snails, are not directly involved in the folding of the mature part, but can facilitate the structure formation by interacting with protein disulfide isomerase in the endoplasmic reticulum (Buczek et al. 2004). It has also been reported that pro-peptides guide the assembly of subunits into active protein complexes as in the case of the von Willebrand factor or caspase-3 (Wise et al. 1988; Feeney and Clark 2005). The pro-peptides of TGF-
and very likely also bone morphogenetic proteins retard the biological activities of the mature growth factors (Böttinger et al. 1996; Degnin et al. 2004; Hillger et al. 2005). While for some pro-peptides their biological activities are displayed even when they are not covalently linked to their mature parts (Gray and Mason 1990), in the case of NGF, the pro-peptide has to be covalently linked to the mature part to promote oxidative structure formation (Rattenholl et al. 2001a). Besides aiding in structure formation, the pro-peptide of proNGF confers a pro-apoptotic activity to the growth factor and thus responses that are completely opposite to the mature growth factor (Lee et al. 2001). Pro-apoptotic responses of proNGF are elicited by binding to a pro-form specific receptor, sortilin (Nykjaer et al. 2004).
Besides their biological relevance, little is known about the structures and stabilities of the various pro-peptides. In the case of the protease subtilisin, the pro-peptide loses the structure in the absence of the mature part (Ruvinov et al. 1997; Buevich et al. 2001). A similar observation was made for the pro-peptide of carboxypeptidase Y: Under conditions where the protein is functional, the pro-peptide is only partially folded. The pro-peptide contains secondary structural elements but a very low content of defined tertiary structure and exists in a molten globule state (Sorenson et al. 1993).
Recently, we demonstrated that the isolated pro-peptide of NGF is a monomeric protein with a distinct secondary structural content. In the isolated form the structure was significantly less stable than in its NGF-coupled form, suggesting an interaction of the pro-peptide and the mature part in native proNGF (Kliemannel et al. 2004). Here, we analyzed in detail the intramolecular interaction of the pro-peptide with the mature part of proNGF and the influence of the mature part on the structure formation process of the covalently linked pro-peptide.
| Results |
|---|
|
|
|---|
|
|
Identification of pro-peptide regions involved in tertiary contacts
In order to identify those regions within the pro-peptide that could be involved in contacts with the mature part, mass spectrometry-coupled H/D exchange was employed. This method allows the identification of segments that are protected against H/D exchange due to their engagement in secondary and/or tertiary structure (Zhang and Smith 1993). For the analysis of the exchange of amide protons in the pro-peptide of proNGF, the protein was incubated in D2O. The exchange reaction was stopped by acidification to minimize a back exchange during the subsequent digestion with pepsin (Supplemental Fig. S1) and preparation for mass analysis (Bai et al. 1993). Analysis of the digestion products showed that the mature part of proNGF is completely intact under the applied experimental conditions. In contrast, defined proteolysis products were obtained from the pro-peptide moiety. The fragments were aligned with the program FindPept (http://www.expasy.ch/tools/findpept.html). The masses of the fragments were analyzed by MALDI-TOF, and exchange rates were corrected for the back exchange determined by control peptides (Table 1).
|
Kinetic analyses of the pro-peptide unfolding and refolding in proNGF
Since the isolated pro-peptide did not alter its tryptophan fluorescence upon denaturation, the change of tryptophan fluorescence of the NGF-coupled pro-peptide should reflect specific tertiary contacts between the pro-peptide and the mature part in proNGF. Folding and unfolding kinetics of the NGF-coupled pro-peptide were analyzed by fluorescence spectroscopy. Changes in spectroscopic signals obtained in a range from 02 M GdmCl originate solely from structural alterations of the pro-peptide, which has been shown previously to possess only a marginal stability (Fig. 1), while the mature part is stable up to 3 M GdmCl (Timm and Neet 1992; De Young et al. 1996; Kliemannel et al. 2004). Folding of the NGF-coupled pro-peptide exhibited a monophasic reaction (Fig. 3A). Since the pro-peptide contains nine prolyl residues, peptidyl prolyl cistrans isomerization could be rate-limiting. However, the folding was neither accelerated by the addition of various peptidyl prolyl cistrans isomerases nor in double-jump experiments (data not shown), indicating that peptidyl prolyl isomerization(s) may not to be a rate-limiting factor.
|
Denaturation kinetics of the NGF-coupled pro-peptide were more complex than refolding kinetics. When denaturation at 1.75 M GdmCl was monitored by fluorescence spectroscopy, a biphasic denaturation process was observed (Fig. 3B). Recording the unfolding by stopped flow CD measurements was not possible at this GdmCl concentration, since the process was too fast to be detectable (Fig. 3B). Thus, upon denaturation, secondary structure is lost first, followed by the disruption of tertiary contacts. This deduced order of reactions is unusual, but matches the data obtained from unfolding equilibria, which also pointed to a first loss of secondary structure(s) before disruption of tertiary contacts (Fig. 2).
In order to analyze whether the biphasic denaturation observed by fluorescence would reflect parallel or serial unfolding reactions with an intermediate accumulating, we performed double-jump experiments. In these experiments, the NGF-coupled pro-peptide was denatured for various times. Subsequently, the protein was transferred to native conditions, and refolding was monitored by fluorescence spectroscopy. When proNGF was denatured for 25 sec in 1.75 M GdmCl, monophasic refolding kinetics were observed. In contrast, upon shorter denaturation times, a biphasic refolding reaction was recorded, with the fast phase
20 times faster than the overall process (Fig. 4A). These data clearly indicate that an intermediate (I) is populated during denaturation. Together with the very fast CD kinetics, these results can be explained by a folding/unfolding scheme N
I1
I2
U. In this scheme, the reaction N
I1 is too fast to be quantified by stopped flow CD and is fluorescenctly silent, whereas the reactions I1
I2 and I2
U represent the fast and slow phases, respectively, observed by fluorescence.
|
A fluorescence spectrum of the intermediate I2 could not be recorded during the unfolding kinetics because the reaction I2
U was too fast. Therefore, denaturation kinetics at 1.8 M GdmCl were measured at different emission wavelengths between 330 and 360 nm. From these kinetic data, the specific fluorescence of the native, intermediate, and denatured state could be calculated and the spectra reconstituted (Fig. 5). The data revealed a wavelength shift of the maximum emission from 340 nm (native state) to 345350 nm (denatured state) already in the intermediate I2. Thus, the solvent accessibility of the tryptophan that is responsible for the change of the fluorescence signal must be similar in I2 and U. It should be noted that the fluorescence intensities of the observed spectra are valid only under the given conditions (1.8 M GdmCl). Since the fluorescence intensity of the spectrum of the intermediate I2 decreases with increasing GdmCl concentrations while that of the native state does not (data not shown), the intermediate possesses a lower fluorescence than the native state at denaturing conditions but a slightly higher fluorescence in the absence of GdmCl. The fluorescence of isolated tryptophan molecules decreases with increasing GdmCl concentrations in a range of 03 M (Schmid 1997). Thus, the decrease in intrinsic fluorescence of the intermediate I2 with increasing GdmCl concentrations indicates the solvent exposure of a tryptophan residue in the intermediate structure. This result is confirmed by the red-shift of the fluorescence maximum of the corresponding spectrum (Fig. 5). Similar fluorescence characteristics of folding intermediates have been observed for other proteins such as antibody fragments (Lilie et al. 1995).
|
I upon refolding. Folding of the intermediate to the native state was measured separately by double-jump experiments, in which native proNGF was submitted to 1.8 M GdmCl for only 1 sec (or 1.2 M GdmCl for 4 sec) to populate the intermediate I2. In the following refolding reaction, the reaction I2
I1/N could be quantified. As mentioned before, the states I1 and N could not be discerned by fluorescence. Therefore, in the following section, the species I1 and N are not distinguished. The results of folding/unfolding are depicted in Figure 6. The global fit of the data yielded microscopic rates of folding and unfolding of N/I1, I2, and U under native conditions as well as the thermodynamic stability of the native and intermediate state I2 (Fig. 6). The overall stability of N/I1
U of the NGF-coupled pro-peptide is 20.9 kJ/mol, which is subdivided in the two transitions N/I1
I2 (14.8 kJ/mol) and I2
U (6.1 kJ/mol). The microscopic unfolding rate of both N/I1 and I2 was identical (ku = 0.0025 sec1); the activation energy was 86.3 kJ/mol. In contrast, the activation energy of folding showed a difference of 8.3 kJ/mol for folding of U and I2, respectively (Supplemental Fig. S2).
|
| Discussion |
|---|
|
|
|---|
It has been shown previously that the pro-peptide acts as an intramolecular chaperone during oxidative folding of proNGF (Rattenholl et al. 2001a,b). This function suggests an interaction of the pro-peptide with folding intermediates of the NGF part based primarily on the properties of the solvent-exposed surface of these intermediates, such as hydrophobicity, rather than well defined structural features. The pro-peptide needs to be covalently attached to NGF in order to exhibit this folding-enhancing function, as the addition of the isolated pro-peptide to folding NGF molecules in trans does not promote folding. This finding indicates a very weak interaction of the pro-peptide with folding intermediates of the mature part (Rattenholl et al. 2001a). In contrast, the intramolecular interaction of the pro-peptide with native NGF is surprisingly stable: It is characterized by an overall energy of
G = 20.9 kJ/mol. Furthermore, one of the transitions reflecting this interaction is highly cooperative (cf. fast phases in Fig. 6), indicating a well defined structural interface between the pro-peptide and NGF. Thus, the intramolecular interaction of the pro-peptide and NGF seems to be quite different in the native state and during folding regarding both structural and thermodynamic parameters.
The experimental data suggest that that the interaction between NGF and its pro-peptide is mediated by a surface area of the mature NGF comprising a tryptophan residue and the peptide Trp83-Ala63 of the pro-peptide. Unfortunately, currently no detailed structural data for the pro-peptide are available. Even the CD spectrum of the NGF-coupled pro-peptide hardly allows a prediction of the overall secondary structural content (Kliemannel et al. 2004). A sequence analysis of the pro-peptide according to the hydrophobic moment method of Eisenberg (Eisenberg et al. 1984) shows that the peptide Trp83-Ala63 possesses the highest hydrophobic moment of the whole pro-peptide. In a helical wheel representation, this peptide is highly amphiphilic with a perfect segregation of hydrophobic and polar/charged amino acids (not shown). However, without structural data of the pro-peptide at the atomic level, a structural interpretation of the pro-peptide region involved in the intramolecular interaction with NGF remains speculative.
As mentioned above, the intramolecular association of NGF with its pro-peptide is mainly of a hydrophobic nature and involves tryptophan residues. The fluorescence change obtained upon unfolding of the NGF-coupled pro-peptide is related to the environmental change of one or more tryptophans. Since a chimeric construct of NGF and the related heterologous pro-peptide of NT-3, which lacks tryptophans, also showed a change in tryptophan fluorescence upon unfolding (A. Hauburger, M. Kliemannel, and E. Schwarz, in prep.), at least part of the fluorescence signal must originate from an altered solvent accessibility of tryptophans of the NGF part. The NGF monomer contains three tryptophans, two of which are located in the dimer interface and thus are buried in the hydrophobic core. These tryptophan residues would presumably not change their spectroscopic properties upon unfolding of the pro-peptide. The third tryptophan of NGF, Trp21, has been identified as the most solvent-exposed and reactive tryptophan residue that is readily modified by N-bromosuccinimide (Cohen et al. 1980). Solvent exposure of this residue has been confirmed by X-ray structure analysis (McDonald et al. 1991; Fig. 7). Our fluorescence data suggest that the pro-peptide shields Trp21 of NGF from solvent since unfolding of the NGF-coupled pro-peptide alters the solvent accessibility of Trp21 of mature NGF. Assuming that the presence of the pro-peptide does not affect the structure of the mature part (especially the dimer interface where the other tryptophans are located), the spectroscopic properties of proNGF would indicate a direct interaction of the pro-peptide with Trp21 of mature NGF.
|
I2 as demonstrated by the fluorescence spectrum of the intermediate I2 (Fig. 5). This reaction and thus the loss of interaction of the pro-peptide with NGF via a region involving Trp21 require an energy input of 14.8 kJ/mol under the given buffer conditions. Assuming a simple model of competition, this energy must be provided by the binding of the receptors to proNGF in order to form a proNGFreceptor complex. Another possibility would be a partial overlap of the binding sites for the pro-peptide and the receptors. In this case it would be conceivable that receptor binding may occur without displacing the pro-peptide. In this scheme the receptor affinity to proNGF would be decreased as well compared with mature NGF. However, depending on the size and the overlapping part of the contact sites for receptor and pro-peptide, the loss of energy in receptor binding due to the presence of the pro-peptide may be smaller than in the displacing model. Although a competition of the pro-peptide with NGF for binding to the receptors TrkA or p75 appears plausible, the precise mode of proNGF receptor interaction remains to be deduced by structural analysis at atomic resolution of proNGF and its receptor complex. | Materials and methods |
|---|
|
|
|---|
Fluorescence spectroscopy
Fluorescence measurements were carried out at a FluoroMax-2 (Jobin-Yvon). Slit widths for both excitation and emission wavelengths were 5 nm. Experiments were performed in 50 mM Na-phosphate, pH 7.0, and 1 mM EDTA at 20°C. Equilibrium transitions of the NGF-coupled pro-peptide (10 µg/mL) were monitored at an excitation wavelength of 280 nm and 325 nm emission. Fluorescence of the isolated pro-peptide (50 µg/mL) was analyzed using an excitation of phenylalanine at 250 nm and after an energy transfer to tryptophan an emission at 345 nm (Kliemannel et al. 2004).
Fluorescence kinetics were carried out either on a FluoroMax 2 using conditions mentioned above or by stopped flow experiments on a SX.18MV spectrometer (Applied Photophysics). In the latter case, fluorescence was detected using a cut-off filter of 320 nm (cp = 0.4 mg/mL) or by single wavelength detection (cp = 1.5 mg/mL). Fluorescence spectra from denaturation kinetics at different emission wavelengths were reconstituted by calculating the specific fluorescence of the native, intermediate, and denatured state using an equation for a serial first-order reaction.
Circular dichroism (CD) spectroscopy
Far UV-CD spectra were recorded on a Jasco J710 spectropolarimeter. Equilibrium transitions of the NGF-coupled pro-peptide (100 µg/mL) were recorded at 220 nm in 50 mM Na-phosphate, pH 7.0 at 20°C in a 1-cm cuvette. Rapid structural changes were followed at 220 nm by stopped flow experiments on a
-star spectropolarimeter (Applied Photophysics). The final protein concentrations of both folding and unfolding reactions were 1 mg/mL.
H/D exchange-coupled MALDI-TOF mass spectrometry
Determination of the deuterium incorporation by exchange of the amide protons of peptide bonds was carried out by MALDI-TOF mass spectrometry using a BRUKER Reflex II mass spectrometer (BRUKER Daltonik GmbH). Experimental details are described in the Supplemental Material. In short, proNGF was incubated in D2O for 2 min. Subsequently, it was digested with pepsin, and the resulting fragments were analyzed by MALDI-ToF. For the alignments of the obtained proteolytic fragments, the program FindPept (http://www.expasy.ch/tools/findpept.html) was used.
| Footnotes |
|---|
Reprint requests to: Elisabeth Schwarz, Martin-Luther-Universität Halle-Wittenberg, Institut für Biotechnologie, Kurt-Mothes-Str. 3, D-06120 Halle, Germany; e-mail: Elisabeth.Schwarz{at}biochemtech.uni-halle.de; fax: + 49 345 55 27 013.
Abbreviations: CD, circular dichroism; GdmCl, guanidinium hydrochloride; NGF, human nerve growth factor; proNGF, pro-form of NGF containing the 102-amino-acid-comprising pro-peptide and a start methionine at the N terminus.
Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.062376207.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
Barde, Y.A.. 1990. The nerve growth factor family. Prog. Growth Factor Res. 2: 237248.[CrossRef][Medline]
Bothwell, M.A. and Shooter, E.M. 1977. Dissociation equilibrium constant of
nerve growth factor. J. Biol. Chem. 252: 85328536.
Böttinger, E.P., Factor, V.M., Tsang, M.L., Weatherbee, J.A., Kopp, J.B., Qian, S.W., Wakefield, L.M., Roberts, A.B., Thorgeirsson, S.S., and Sporn, M.B. 1996. The recombinant proregion of transforming growth factor
1 (latency-associated peptide) inhibits active transforming growth factor
1 in transgenic mice. Proc. Natl. Acad. Sci. 93: 58775882.
Bradshaw, R.A., Blundell, T.L., Lapatto, R., McDonald, N.Q., and Murray-Rust, J. 1993. Nerve growth factor revisited. Trends Biochem. Sci. 18: 4852.[CrossRef][Medline]
Buczek, O., Olivera, B.M., and Bulaj, G. 2004. Propeptide does not act as an intramolecular chaperone but facilitates protein disulfide isomerase-assisted folding of a conotoxin precursor. Biochemistry 43: 10931101.[Medline]
Buevich, A.V., Shinde, U.P., Inouye, M., and Baum, J. 2001. Backbone dynamics of the natively unfolded pro-peptide of subtilisin by heteronuclear NMR relaxation studies. J. Biomol. NMR 20: 233249.[CrossRef][Medline]
Casaccia-Bonnefil, P., Carter, B.D., Dobrowsky, R.T., and Chao, M.V. 1996. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383: 716719.[CrossRef][Medline]
Cohen, P., Sutter, A., Landreth, G., Zimmermann, A., and Shooter, E.M. 1980. Oxidation of tryptophan-21 alters the biological activity and receptor binding characteristics of mouse nerve growth factor. J. Biol. Chem. 255: 29492954.
De Young, L.R., Burton, L.E., Liu, J., Powell, M.F., Schmelzer, C.H., and Skelton, N.J. 1996. RhNGF slow unfolding is not due to proline isomerization: Possibility of a cystine knot loop-threading mechanism. Protein Sci. 5: 15541566.[Abstract]
Degnin, C., Jean, F., Thomas, G., and Christian, J.L. 2004. Cleavages within the prodomain direct intracellular trafficking and degradation of mature bone morphogenetic protein-4. Mol. Biol. Cell 15: 50125020.
Drinkwater, C.C., Suter, U., Angst, C., and Shooter, E.M. 1991. Mutation of tryptophan-21 in mouse nerve growth factor (NGF) affects binding to the fast NGF receptor but not induction of neurites on PC12 cells. Proc. Biol. Sci. 246: 307313.
Eisenberg, D., Weiss, R.M., and Terwilliger, T.C. 1984. The hydrophobic moment detects periodicity in protein hydrophobicity. Proc. Natl. Acad. Sci. 81: 140144.
Ernfors, P., Ibanez, C.F., Ebendal, T., Olson, L., and Persson, H. 1990. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: Developmental and topographical expression in the brain. Proc. Natl. Acad. Sci. 87: 54545458.
Fahnestock, M., Yu, G., and Coughlin, M.D. 2004. ProNGF: A neurotrophic or an apoptotic molecule? Prog. Brain Res. 146: 107110.
Fairlie, W.D., Zhang, H.P., Wu, W.M., Pankhurst, S.L., Bauskin, A.R., Russell, P.K., Brown, P.K., and Breit, S.N. 2001. The propeptide of the transforming growth factor-
superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion. J. Biol. Chem. 276: 1691116918.
Feeney, B. and Clark, A.C. 2005. Reassembly of active caspase-3 is facilitated by the propeptide. J. Biol. Chem. 280: 3977239785.
Frade, J.M., Rodriguez-Tebar, A., and Barde, Y.A. 1996. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383: 166168.[CrossRef][Medline]
Gallagher, T., Gilliland, G., Wang, L., and Bryan, P. 1995. The prosegment-subtilisin BPN' complex: Crystal structure of a specific foldase.. Structure 3: 907914.[Medline]
Gray, A.M. and Mason, A.J. 1990. Requirement for activin A and transforming growth factor
1 pro-regions in homodimer assembly. Science 247: 13281330.
Hasan, W., Pedchenko, T., Krizsan-Agbas, D., Baum, L., and Smith, P.G. 2003. Sympathetic neurons synthesize and secrete pro-nerve growth factor protein. J. Neurobiol. 57: 3853.[CrossRef][Medline]
He, X.L. and Garcia, K.C. 2004. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 304: 870875.
Hidaka, Y., Ohno, M., Hemmasi, B., Hill, O., Forssmann, W.G., and Shimonishi, Y. 1998. In vitro disulfide-coupled folding of guanylyl cyclase-activating peptide and its precursor protein. Biochemistry 37: 84988507.[CrossRef][Medline]
Hillger, F., Herr, G., Rudolph, R., and Schwarz, E. 2005. Biophysical comparison of BMP-2, ProBMP-2, and the free pro-peptide reveals stabilization of the pro-peptide by the mature growth factor. J. Biol. Chem. 280: 1497414980.
Hohn, A., Leibrock, J., Bailey, K., and Barde, Y.A. 1990. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344: 339341.[CrossRef][Medline]
Ikemura, H., Takagi, H., and Inouye, M. 1987. Requirement of pro-sequence for the production of active subtilisin E in Escherichia coli . J. Biol. Chem. 262: 78597864.
Jain, S.C., Shinde, U., Li, Y., Inouye, M., and Berman, H.M. 1998. The crystal structure of an autoprocessed Ser221Cys-subtilisin E-propeptide complex at 2.0 Å resolution. J. Mol. Biol. 284: 137144.[CrossRef][Medline]
Kliemannel, M., Rattenholl, A., Golbik, R., Balbach, J., Lilie, H., Rudolph, R., and Schwarz, E. 2004. The mature part of proNGF induces the structure of its pro-peptide. FEBS Lett. 566: 207212.[CrossRef][Medline]
LaLonde, J.M., Zhao, B., Janson, C.A., D'Alessio, K.J., McQueney, M.S., Orsini, M.J., Debouck, C.M., and Smith, W.W. 1999. The crystal structure of human procathepsin K. Biochemistry 38: 862869.[CrossRef][Medline]
Lee, R., Kermani, P., Teng, K.K., and Hempstead, B.L. 2001. Regulation of cell survival by secreted proneurotrophins. Science 294: 19451948.
Lilie, H., Jaenicke, R., and Buchner, J. 1995. Characterization of a quaternary-structured folding intermediate of an antibody Fab-fragment. Protein Sci. 4: 917924.[Abstract]
McDonald, N.Q., Lapatto, R., Murray-Rust, J., Gunning, J., Wlodawer, A., and Blundell, T.L. 1991. New protein fold revealed by a 2.3-Å resolution crystal structure of nerve growth factor. Nature 354: 411414.[CrossRef][Medline]
Nykjaer, A., Lee, R., Teng, K.K., Jansen, P., Madsen, P., Nielsen, M.S., Jacobsen, C., Kliemannel, M., Schwarz, E., and Willnow, T.E., et al. 2004. Sortilin is essential for proNGF-induced neuronal cell death. Nature 427: 843848.[CrossRef][Medline]
Podobnik, M., Kuhelj, R., Turk, V., and Turk, D. 1997. Crystal structure of the wild-type human procathepsin B at 2.5 Å resolution reveals the native active site of a papain-like cysteine protease zymogen. J. Mol. Biol. 271: 774788.[CrossRef][Medline]
Rattenholl, A., Lilie, H., Grossmann, A., Stern, A., Schwarz, E., and Rudolph, R. 2001a. The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies. Eur. J. Biochem. 268: 32963303.[Medline]
Rattenholl, A., Ruoppolo, M., Flagiello, A., Monti, M., Vinci, F., Marino, G., Lilie, H., Schwarz, E., and Rudolph, R. 2001b. Pro-sequence assisted folding and disulfide bond formation of human nerve growth factor. J. Mol. Biol. 305: 523533.[CrossRef][Medline]
Ruvinov, S., Wang, L., Ruan, B., Almog, O., Gilliland, G.L., Eisenstein, E., and Bryan, P.N. 1997. Engineering the independent folding of the subtilisin BPN' prodomain: Analysis of two-state folding versus protein stability. Biochemistry 36: 1041410421.[CrossRef][Medline]
Schmid, F.X.. 1997. Spectral methods of characterizing protein conformation and conformational changes. In Protein structure: A practical approach (ed. T.E. Creighton), pp. 261297. IRL-Press, Oxford, United Kingdom.
Seidah, N.G., Benjannet, S., Pareek, S., Savaria, D., Hamelin, J., Goulet, B., Laliberte, J., Lazure, C., Chretien, M., and Murphy, R.A. 1996. Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. Biochem. J. 314: 951960.
Shinde, U. and Inouye, M. 2000. Intramolecular chaperones: Polypeptide extensions that modulate protein folding. Semin. Cell Dev. Biol. 11: 3544.[CrossRef][Medline]
Shinde, U., Li, Y., Chatterjee, S., and Inouye, M. 1993. Folding pathway mediated by an intramolecular chaperone. Proc. Natl. Acad. Sci. 90: 69246928.
Sorenson, P., Winther, J.R., Kaarsholm, N.C., and Poulsen, F.M. 1993. The pro region required for folding of carboxypeptidase Y is a partially folded domain with little regular structural core. Biochemistry 32: 1216012166.[CrossRef][Medline]
Timm, D.E. and Neet, K.E. 1992. Equilibrium denaturation studies of mouse
-nerve growth factor. Protein Sci. 1: 236244.[Abstract]
Weissman, J.S. and Kim, P.S. 1992. The pro region of BPTI facilitates folding. Cell 71: 841851.[CrossRef][Medline]
Wiesmann, C., Ultsch, M.H., Bass, S.H., and de Vos, A.M. 1999. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 401: 184188.[CrossRef][Medline]
Winther, J.R. and Sorensen, P. 1991. Propeptide of carboxypeptidase Y provides a chaperone-like function as well as inhibition of the enzymatic activity. Proc. Natl. Acad. Sci. 88: 93309334.
Wise, R.J., Pittman, D.D., Handin, R.I., Kaufman, R.J., and Orkin, S.H. 1988. The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell 52: 229236.[CrossRef][Medline]
Zhang, Z. and Smith, D.L. 1993. Determination of amide hydrogen exchange by mass spectrometry: A new tool for protein structure elucidation. Protein Sci. 2: 522531.[Abstract]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Boutilier, C. Ceni, P. C. Pagdala, A. Forgie, K. E. Neet, and P. A. Barker Proneurotrophins Require Endocytosis and Intracellular Proteolysis to Induce TrkA Activation J. Biol. Chem., May 9, 2008; 283(19): 12709 - 12716. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |